###begin article-title 0
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
Natural antisense transcript of natriuretic peptide precursor A (NPPA): structural organization and modulation of NPPA expression
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 444 449 <span type="species:ncbi:9606">human</span>
Mammalian transcriptome contains a large proportion of diverse and structurally complex noncoding RNAs. One class of such RNAs, natural antisense transcripts (NATs), are derived from the opposite strand of many protein-coding genes. Although the exact structure and functional relevance of most of the NATs is unknown, their emerging role as gene expression regulators raises the hypothesis that NATs might contribute to development of complex human disorders. The goal of our study was to investigate the involvement of NATs in regulation of candidate genes for blood pressure.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 100 110 100 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In silico </italic>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADD3</italic>
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP1A1</italic>
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPR2</italic>
###xml 172 179 172 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP17A1</italic>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACSM3</italic>
###xml 188 195 188 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC14A2</italic>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 313 320 313 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 352 360 352 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 461 469 461 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 473 478 473 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 500 507 500 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 546 554 546 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 612 617 612 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 675 683 675 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 723 731 723 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa-as </italic>
###xml 388 393 <span type="species:ncbi:9606">human</span>
###xml 745 750 <span type="species:ncbi:10090">mouse</span>
First we analysed blood pressure candidate genes for the presence of natural antisense transcripts. In silico analysis revealed that seven genes (ADD3, NPPA, ATP1A1, NPR2, CYP17A1, ACSM3, SLC14A2) have an antisense partner transcribed from the opposite strand. We characterized NPPA and its antisense transcript (NPPA-AS) in more detail. We found that NPPA-AS is expressed in a number of human tissues as a collection of alternatively spliced isoforms and that NPPA-AS and NPPA can form RNA duplexes in vivo. We also demonstrated that a specific NPPA-AS isoform is capable of down-regulating the intron-retained NPPA mRNA variant. We studied the evolutionary conservation of NPPA-AS and were able to detect the presence of Nppa-as transcript in mouse.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 50 58 50 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
Our results demonstrate functional interaction of NPPA-AS with NPPA at the RNA level and suggest that antisense transcription might be an important post-transcriptional mechanism modulating NPPA expression.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 274 275 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 440 441 440 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 533 534 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
A number of large-scale transcriptional mapping studies have shown that the mammalian transcriptome is extremely complex not only due to alternative splicing but also (and maybe primarily) because of the abundance of noncoding and often overlapping transcriptional units [1-4]. This has raised the hypothesis of RNA-based regulatory system that has allowed the elaboration and expansion of phenotypic complexity of multicellular organisms [5]. It appears that the transcription from both strands in eukaryotic genomes is widespread [6-10], resulting in a large pool of complementary RNAs, or natural sense-antisense transcript pairs. The diversity and extent of antisense transcription suggests that this may be an important and common mechanism of gene expression modulation (recently reviewed in [11-13]).
###end p 9
###begin p 10
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 209 210 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1062 1064 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1142 1147 1142 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Zeb2 </italic>
###xml 1251 1256 1251 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Zeb2 </italic>
###xml 1372 1374 1372 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1610 1612 1610 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1025 1030 <span type="species:ncbi:10090">mouse</span>
###xml 1747 1752 <span type="species:ncbi:9606">human</span>
Depending on the methodological approach and criteria for antisense transcript detection, the estimates of the proportion of transcripts involved in formation of sense-antisense pairs varies from 20 to 40% [2,6-10]. Majority of the natural antisense transcripts (NATs) originate from the opposite DNA strand of the same locus as the sense transcript (cis-NATs). In some cases, NATs can be transcribed from different loci on the genome (trans-NATs) [14]. Although high-throughput studies have investigated expression pattern and evolution of antisense transcripts on a genome-wide scale, the direct regulatory role of NATs has been demonstrated only in a few cases. The mode of NAT action includes very different mechanisms like transcriptional interference [15], RNA masking [16], and epigenetic silencing by triggering heterochromatin formation [17]. In addition, other double-stranded RNA dependant mechanisms like RNA editing or RNA interference may be involved. It has been shown that bidirectionally transcribed loci in mouse can produce endogenous siRNAs [14] and therefore may regulate gene expression by means of RNAi. In the case of Zeb2 (zinc finger E-box binding homeobox 2) expression regulation, a NAT masks one of the 5' splice sites of Zeb2 pre-mRNA, thereby causing the retention of regulatory intron that is necessary for the translation of Zeb2 protein [16]. Strong phenotypic effect of antisense transcription was shown in a specific case of thalassemia which is caused by a deletion leading to aberrant antisense transcription and silencing of a neighboring gene by CpG island methylation [18]. The potential role of NATs in the regulation of gene expression raises the hypothesis that they might contribute to complex genetic human disorders such as cardiovascular disease, cancer, diabetes or mental disorders.
###end p 10
###begin p 11
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
The goal of the present study was to investigate whether natural antisense transcripts are involved in regulation of candidate genes for hypertension. We proposed that the functional variation of candidate genes might be affected by the interaction with regulatory factors, including non-coding antisense RNAs. We focused on the genes with demonstrated role in familial forms of hypo- and hypertension from a salt-water homeostasis pathway [19-21].
###end p 11
###begin p 12
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADD3</italic>
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 73 79 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP1A1</italic>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPR2</italic>
###xml 87 94 87 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP17A1</italic>
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACSM3</italic>
###xml 103 110 103 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC14A2</italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 228 235 228 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 615 620 615 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 770 774 770 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
We identified seven genes that are associated with cis-NATs (ADD3, NPPA, ATP1A1, NPR2, CYP17A1, ACSM3, SLC14A2). Detailed analysis was carried out for NPPA (natriuretic peptide precursor A) and its natural antisense transcript, NPPA-AS. NPPA codes for a precursor of atrial natriuretic peptide (ANP) that protects the cardiovascular system from the volume and pressure overload by decreasing vascular smooth muscle tone. Common genetic variants at the NPPA locus that are associated with the higher ANP concentration are also associated with lower blood pressure and reduced risk of hypertension [22]. In addition, NPPA expression is tightly regulated during the embryonic heart development [23,24], suggesting that complex regulatory mechanisms control the activity of NPPA.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Natural antisense transcripts associated with candidate genes for blood pressure regulation
###end title 14
###begin p 15
###xml 57 58 57 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADD3</italic>
###xml 300 304 300 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 306 312 306 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ATP1A1</italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPR2</italic>
###xml 320 327 320 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP17A1</italic>
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACSM3</italic>
###xml 336 343 336 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC14A2</italic>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 525 527 525 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AS</italic>
###xml 669 670 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 742 749 742 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADD3-AS</italic>
###xml 1043 1048 1043 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPR2 </italic>
###xml 1091 1097 1091 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPAG8 </italic>
###xml 1118 1119 1118 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1143 1149 1143 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EXOD1 </italic>
###xml 1188 1194 1188 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACSM3 </italic>
###xml 1215 1216 1215 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1314 1322 1314 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADD3-AS </italic>
###xml 1326 1334 1326 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
We first identified candidate genes [see Additional file 1 - Table S1] with the evidence of antisense transcription by screening them against published sense-antisense pairs [8] and scanning for expressed sequence tags (ESTs) on opposite strand using UCSC Genome Browser . We found that seven (ADD3, NPPA, ATP1A1, NPR2, CYP17A1, ACSM3, SLC14A2) out of 38 genes tested had multiexon NATs supported by a number of ESTs with canonical GT-AG splice donor-acceptor sites (Table 1). The antisense transcripts (indicated by suffix -AS, that stands for 'antisense') differ from each other in their organization and complementarity in respect to sense mRNA [see Additional file 2 - Figure S1]. The 5'-most exons of antisense transcript for adducin 3, ADD3-AS, have complementarity to 5' UTR exons of the sense gene (5'-5' overlap). In other cases, the overlap pattern is more complex, involving one or several internal exons and intron-exon boundaries. In two cases, the transcript from opposite strand has been annotated as a protein-coding mRNA: (i) NPR2 3'-most exon is partially complementary to SPAG8 [see Additional file 2 - Figure S1D] and (ii) EXOD1 is transcribed from opposite strand of ACSM3 [see Additional file 2 - Figure S1F]. In addition, the open reading frame (ORF) is predicted for one of the isoforms of ADD3-AS and NPPA-AS (99 and 121 amino acids, respectively). Taken together, these data indicate that antisense transcripts associated with blood pressure candidate genes have diverse structure and various relationships to their sense partners.
###end p 15
###begin p 16
Hypertension candidate genes associated with antisense transcripts.
###end p 16
###begin p 17
* Number of sense gene exons involved in sense-antisense complementarity. section sign A gene symbol or a GenBank accession of a representative EST or mRNA and a total number of ESTs in antisense cluster. ORF - open reading frame (only ORFs larger than 90 aa are shown), UTR - untranslated region, aa - amino acids.
###end p 17
###begin title 18
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 36 41 <span type="species:ncbi:9606">human</span>
Structure and expression of NPPA in human tissues
###end title 18
###begin p 19
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 162 170 162 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 499 504 <span type="species:ncbi:9606">human</span>
For further studies we selected NPPA and its antisense transcript, NPPA-AS (Figure 1A). This sense-antisense pair was selected for functional studies because (i) NPPA-AS is represented by a cluster of alternatively spliced ESTs and overlaps with the exons, introns as well as with intron-exon boundaries of NPPA, raising the hypothesis that it could have a posttranscriptional regulatory role in NPPA expression and (ii) NPPA has a compact size, consisting of only three exons and spanning ~2 kb on human chromosome 1p36.22 that makes it a good model system for examination of the functional role of antisense transcription.
###end p 19
###begin p 20
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Splicing isoforms and expression pattern of <italic>NPPA </italic>and <italic>NPPA-AS</italic></bold>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 122 130 122 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 370 375 370 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 388 396 388 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 504 509 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 564 576 564 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA+Intr1+2</italic>
###xml 590 600 590 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA+Intr1</italic>
###xml 817 822 817 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 941 950 941 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS.9</italic>
###xml 1092 1097 1092 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 1101 1109 1101 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 1273 1281 1273 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
Splicing isoforms and expression pattern of NPPA and NPPA-AS. (A) Genomic structure of NPPA and its antisense transcript, NPPA-AS (represented by several overlapping ESTs). Arrowheads indicate the direction of transcription, vertical lines depict the overlap between sense and antisense exons. The length of complementary region is shown in basepairs. Coding regions of NPPA and putative NPPA-AS ORF are represented as black boxes, noncoding exons and UTRs as white boxes. (B) The expression analysis of NPPA demonstrates the presence of intron-retained variants (NPPA+Intr1+2, 1820 bp and NPPA+Intr1, 722 bp) in a number of tissues. PCR reactions were performed using the primers NPPA-F and NPPA-R (indicated by arrows labeled F and R on Figure 1C) and resolved on an agarose gel. Expected size of correctly spliced NPPA product is 600 bp. The shorter product in testis (457 bp) represents a testis-specific isoform of antisense transcript NPPA-AS.9, which was not represented by ESTs in the databank and therefore could not be avoided when designing primers. (C) The schematic depiction of NPPA and NPPA-AS splicing isoforms, the products of 3' RACE reactions and their location on the genomic sequence. The gray block arrows indicate the direction of transcription. (D) NPPA-AS is widely expressed as a complex combination of alternatively spliced isoforms. Upper panel: the agarose gel showing the reactions performed using primers NPPA-AS-F4 and NPPA-AS-R1 (indicated by arrows labeled F4 and R1 on Figure 1C) on the panel of tissue-specific cDNAs. Lower panel: Isoform 3'RACE.2 is expressed only in testis. PCR was performed using primers NPPA-AS-F1 and NPPA-AS-R5 (indicated by arrows labeled F1 and R5 on Figure 1C). The band corresponds to the expected size of 405 bp.
###end p 20
###begin p 21
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 111 116 111 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B, C</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 335 340 335 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 406 411 406 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 462 474 462 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA+Intr1+2</italic>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 601 606 601 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 753 763 753 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA+Intr1</italic>
###xml 820 825 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 1054 1061 1054 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 1161 1174 1161 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA+Intr1+2 </italic>
###xml 1298 1305 1298 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 1315 1320 1315 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 1341 1342 1341 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1365 1370 1365 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 1374 1382 1374 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 1511 1519 1511 1519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 1614 1621 1614 1621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 1702 1715 1702 1715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA+Intr1+2 </italic>
###xml 56 61 <span type="species:ncbi:9606">Human</span>
We investigated the expression of NPPA using commercial Human Multiple Tissue cDNA panels MTC I and II (Figure 1B, C). Consistent with previous studies [23-25], the strongest expression of NPPA was detected in heart, but several tissues contained additional alternative products. Sequencing of these products revealed that the largest NPPA band detected in many tissues (1820 bp) represents the isoform of NPPA with retained both introns (further referred to as NPPA+Intr1+2). Visual inspection of the agarose gel (Figure 1B) indicates that the expression of this unspliced form and correctly spliced NPPA appear to be inversely correlated. Alternative product of 722 bp that was observed in liver, testis and leukocytes contains the retained intron 1 (NPPA+Intr1). In addition, a product shorter than correctly spliced NPPA mRNA (457 bp) was detected in testis. Sequencing of this product revealed that its sequence and splicing pattern are similar to the transcripts originating from the opposite strand, suggesting that this is actually an isoform of NPPA-AS, which was not represented by any of the ESTs in the database. To ensure that the amplification of NPPA+Intr1+2 is not caused by genomic DNA contamination, additional PCR experiments were performed with several primers that detect only NPPA-AS, but not NPPA [see Additional file 2 - Figure S2]. Because NPPA and NPPA-AS are both transcribed from the same genomic locus, contamination with the genomic DNA should result in amplification of unspliced NPPA-AS as well. However, these reactions yielded only the products corresponding to correctly spliced NPPA-AS, indicating no presence of the genomic contamination and demonstrating that the NPPA+Intr1+2 isoform indeed represents mRNA with retained introns.
###end p 21
###begin title 22
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
NPPA-AS is expressed as a collection of alternatively spliced isoforms
###end title 22
###begin p 23
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 138 143 138 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C, D</xref>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 317 325 317 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 74 79 <span type="species:ncbi:9606">human</span>
Next, we characterized the structure and expression profile of NPPA-AS in human tissues using the panel of tissue-specific cDNAs (Figures 1C, D). Sequencing of eight identified isoforms confirmed that they all are spliced according to GT-AG consensus rule [see Additional file 2 - Figures S3 and S4]. It appears that NPPA-AS isoforms are not a result of alternative usage of different exons, but rather almost every exon displays at least two alternative splice donor/acceptor sites (Figure 1C). Majority of the alternative splicing events occur at the acceptor site of the intron. In addition, clearly identifiable polypyrimidine tract is located close to the splice acceptor site of all introns.
###end p 23
###begin p 24
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 205 209 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 555 560 555 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1045 1052 1045 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAPOLG </italic>
###xml 1058 1060 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1250 1258 1250 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
Next, we mapped the 3' end of NPPA-AS by RACE using RNA from HeLa cell line. We designed the gene-specific primers that would identify the 3' variants that are important in respect of complementarity with NPPA. Sequencing of the 3' RACE products identified two alternative 3' ends of NPPA-AS. One of the RACE products confirmed the presence of 3'-terminal exon that was predicted based on EST sequences CD368210 and BU732528 (3'RACE.1, Figure 1C). In addition, we identified a novel 3'-terminal exon that overlaps with the second intron and third exon of NPPA (3'RACE.2, Figure 1C). Expression analysis of the 3'RACE.2 isoform showed that among the sixteen tissues analysed, it is expressed only in testis (Figure 1D). Isoform 3'RACE.1 contains a suboptimal AGTAAA poly(A) signal 16 nucleotides upstream of the cleavage site, in the position where the majority of poly(A) signals are located [26]. 3'RACE.2 isoform does not contain a detectable polyadenylation signal, but an A-rich element (AAAGAGAACACAGACATA), similar to the element found in PAPOLG gene [27], that is also lacking any poly(A) signal variant, is located 19 nucleotides upstream of polyadenylation site. This suggests that in addition to alternative splicing, the processing of the NPPA-AS transcript might be regulated also at the level of polyadenylation.
###end p 24
###begin title 25
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
Primary sequence of NPPA-AS is not evolutionarily conserved
###end title 25
###begin p 26
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa </italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa </italic>
###xml 316 324 316 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa-as </italic>
###xml 624 632 624 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa-as </italic>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 709 714 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa </italic>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 957 962 957 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 1043 1045 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1154 1159 1154 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 1172 1174 1172 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
###xml 327 332 <span type="species:ncbi:10090">mouse</span>
###xml 380 385 <span type="species:ncbi:10090">mouse</span>
###xml 584 589 <span type="species:ncbi:10090">mouse</span>
###xml 831 836 <span type="species:ncbi:10090">mouse</span>
###xml 841 846 <span type="species:ncbi:9606">human</span>
###xml 1065 1070 <span type="species:ncbi:10090">mouse</span>
###xml 1078 1083 <span type="species:ncbi:9606">human</span>
To address the evolutionary conservation of NPPA-AS, we first asked whether Nppa gene in mouse is associated with similar natural antisense transcript. Two ESTs (GenBank: and  representing the 5' and 3' end of the IMAGE clone 6400656) at the Nppa locus originate from the opposite strand and therefore may represent Nppa-as in mouse. These ESTs are isolated from the brain of the mouse at embryonic day 12.5. Both ESTs follow the GT-AG splicing consensus, and CO043998 contains a canonical polyadenylation signal AATAAA as well as a short poly(A) tail. RT-PCR using RNA isolated from mouse tissues showed weak expression of Nppa-as in brain and very faint signal in liver (Figure 2A), while the expression of Nppa was present in all tissues that were tested (heart, brain, lung, liver, kidney and spleen) (Figure 2A). Exons of the mouse and human antisense transcript are not conserved at the primary structure level outside of the overlap regions with the NPPA exons and are located at the different positions in the genomic sequence (Figure 2B). However, both in mouse and in human, the antisense transcript overlaps with the intron-exon boundaries of NPPA gene (Figure 2B).
###end p 26
###begin p 27
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa </italic>
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa-as </italic>
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression analysis of <italic>Nppa </italic>and <italic>Nppa-as </italic>in mouse tissues</bold>
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa </italic>
###xml 116 124 116 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa-as </italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa </italic>
###xml 205 213 205 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa-as </italic>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 664 669 664 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 690 698 690 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 753 758 753 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
###xml 381 386 <span type="species:ncbi:10090">mouse</span>
###xml 391 396 <span type="species:ncbi:9606">human</span>
###xml 478 483 <span type="species:ncbi:9606">human</span>
Expression analysis of Nppa and Nppa-as in mouse tissues. (A) Nppa is expressed in all tissues that were tested and Nppa-as is expressed in the brain. Nppa was amplified using primers mNppa-F and mNppa-R, Nppa-as was detected using primers mNppa-asF and mNppa-asR (indicated by arrows marked F, R, asF and asR on Figure 2B, respectively). (B) Genomic organization of NPPA locus in mouse and human. Arrowheads indicate the direction of transcription. Conservation profile of the human sequence, based on the UCSC vertebrate conservation track is shown below. Conservation is detected in the coding region (depicted as black boxes), promoter area and 3' terminus of NPPA gene, but not in the NPPA-AS exons that are located in introns or downstream of the NPPA gene.
###end p 27
###begin p 28
###xml 17 25 17 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 50 52 50 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 254 264 254 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 317 322 <span type="species:ncbi:9606">human</span>
###xml 327 337 <span type="species:ncbi:9598">chimpanzee</span>
###xml 649 654 <span type="species:ncbi:9606">human</span>
###xml 659 669 <span type="species:ncbi:9598">chimpanzee</span>
The last exon of NPPA-AS 3'RACE.1 isoform (Figure 1C, represented also by ESTs GenBank: and ) contains an open reading frame (ORF) that is predicted to code for a protein of 121 amino acids [see Additional file 2 - Figure S5]. The multiple alignment and in silico translation demonstrate that in all organisms except human and chimpanzee, the predicted ORF is interrupted by at least one frameshift and one stop codon [see Additional file 2 - Figures S5A and S6]. Since the translated amino acid sequence does not contain any conserved domains and has no significant identity above 30% to any known protein, the function of the predicted protein in human and chimpanzee cannot be assessed based on the primary sequence.
###end p 28
###begin title 29
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
Positive correlation between the expression levels of intron-retained NPPA and specific NPPA-AS isoforms
###end title 29
###begin p 30
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 67 74 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 112 120 112 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 241 249 241 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 258 268 258 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS.1 </italic>
###xml 272 274 272 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2 </italic>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 555 560 555 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 686 694 686 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 698 703 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 887 895 887 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 917 922 917 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 1027 1035 1027 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 1084 1088 1084 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 164 169 <span type="species:ncbi:9606">Human</span>
To study the correlation between the expression levels of NPPA and NPPA-AS, we quantified the specific NPPA and NPPA-AS isoforms using real-time PCR and commercial Human Multiple Tissue cDNA panels MTC I and II (Figure 3). We focused on the NPPA-AS isoforms NPPA-AS.1 and 2 (Figure 3B) that are complementary to the first intron and first and second exon of NPPA, including intron-exon boundaries. These are the isoforms that most likely have an impact on NPPA expression regulation. We detected no correlation between the expression of correctly spliced NPPA and its antisense transcript (Figure 3A), but instead observed a strong positive correlation between the expression levels of NPPA-AS and NPPA variants with retained intron 1 (Spearman's rank correlation coefficient = 0.77, p-value = 0.0028). This result was confirmed by using an alternative set of primers detecting the same NPPA-AS isoforms and retained NPPA intron 1 (data not shown). Such correlation further indicates a possible functional relationship between NPPA-AS expression and posttranscriptional regulation of NPPA.
###end p 30
###begin p 31
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 60 68 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 0 156 0 156 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression levels of <italic>NPPA </italic>variants with retained intron and <italic>NPPA-AS </italic>are highly correlated (Spearman's rank correlation coefficient = 0.77, p-value = 0.0028)</bold>
###xml 183 191 183 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 461 467 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 584 589 584 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 593 600 593 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 384 389 <span type="species:ncbi:9606">human</span>
Expression levels of NPPA variants with retained intron and NPPA-AS are highly correlated (Spearman's rank correlation coefficient = 0.77, p-value = 0.0028). (A) Expression levels of NPPA-AS (a total of isoforms 1 and 2) and NPPA (spliced and intron-retained forms were detected separately using primers shown on Figure 3B) were determined by quantitative real-time PCR on a panel of human tissue-specific cDNAs. Expression levels were normalized to endogenous GAPDH mRNA. (B) Schematic depiction of primer positions (black arrows) that were used to quantify the expression levels of NPPA and NPPA-AS. To the right are indicated the symbols that are used for each reaction in Figure 3A.
###end p 31
###begin title 32
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
NPPA-AS as a modulator of expression of NPPA splicing isoforms
###end title 32
###begin p 33
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 244 249 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 328 336 328 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 345 355 345 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS.1 </italic>
###xml 359 361 359 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2 </italic>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 510 518 510 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
To test the hypothesis that NPPA-AS has a regulatory role in the splicing of NPPA mRNA, we constructed expression vectors containing either NPPA gene or one of the four antisense transcript isoforms with different regions of complementarity to NPPA (Figure 4A). Constructs pNPPA-AS-1, -2, -3 and -4 were generated by cloning of NPPA-AS isoforms NPPA-AS.1 and 2 and3'RACE products 3'RACE.1 and 3'RACE.2, respectively, into the expression vector pQM-Ntag/A. Generation of different constructs expressing NPPA or NPPA-AS isoforms allows to test the effect of each antisense variant separately and eliminates the possible influence of transcriptional interference as a mechanism of antisense action.
###end p 33
###begin p 34
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>NPPA-AS </italic>constructs modulate the level of intron-retained <italic>NPPA </italic>variants</bold>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 313 318 313 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 480 488 480 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 738 744 738 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 748 753 748 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HPRT1</italic>
###xml 406 411 <span type="species:ncbi:10090">Mouse</span>
NPPA-AS constructs modulate the level of intron-retained NPPA variants. (A) Schematic depiction of expression constructs and oligonucleotide primers that were used to quantify spliced NPPA (NPPA-Ex1Ex2-F and NPPA-Ex2-R) or the variants with retained intron 1 (NPPA-In1Ex2-F and NPPA-Ex2-R). (B) The expression of NPPA intron-retained form was reduced significantly in case of coexpression with pNPPA-AS-1. Mouse NIH3T3 cells were cotransfected with pNPPA-mg2 along with different NPPA-AS expression constructs depicted above or empty vector as a control. Relative expression levels of spliced (left panel) and intron-retained (right panel) NPPA mRNA were analysed by real-time quantitative PCR. The geometric mean of two reference genes, GAPDH and HPRT1, was used as an endogenous control. The results are represented as arbitrary units based on relative quantity at the logarithmic scale. Error bars show s.e.m. P-value was calculated using Mann-Whitney Test.
###end p 34
###begin p 35
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 121 129 121 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 347 352 347 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 356 363 356 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 392 400 392 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 625 627 625 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 759 763 759 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
###xml 231 236 <span type="species:ncbi:10090">Mouse</span>
We cotransfected NPPA expression construct into the mouse embryonic fibroblast cell line NIH3T3 in pairs with individual NPPA-AS constructs and quantified correctly spliced and intron-retained variants of NPPA by real-time RT-PCR. Mouse cell line was selected for transfection in order to eliminate the possible effect of endogenous expression of NPPA and NPPA-AS. The expression of specific NPPA-AS isoforms in transfected cells was confirmed by quantitative RT-PCR (data not shown). As shown in Figure 4B, expression level of intron-retained NPPA variant was significantly downregulated after transfection with pNPPA-AS-1 (P = 0.002, Mann-Whitney test). Although all constructs caused slight changes in expression levels of both spliced and intron-retained NPPA, the effects did no reach statistical significance in other experiments.
###end p 35
###begin p 36
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 60 68 60 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 182 190 182 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 511 516 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 609 613 609 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 689 694 689 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 698 706 698 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 752 760 752 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 769 778 769 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS.1</italic>
###xml 827 831 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
To further test whether complementary sequences of NPPA and NPPA-AS actually can form RNA duplexes, we performed RT-PCR on RNase treated RNA samples from cotransfections of NPPA and NPPA-AS constructs pNPPA-AS-1 and 3 (Figure 5). In both cases, the product with the correct size from RNase-treated samples was obtained, indicating that NPPA and its antisense transcript indeed form duplex RNAs. pNPPA-AS-3 has complementarity only to exonic regions of NPPA and can form a duplex with both spliced and unspliced NPPA mRNA. In the case of pNPPA-AS-1 we detected the duplex formation with the intronic region of NPPA, which can occur only with unspliced pre-mRNA. These results indicate that NPPA and NPPA-AS interact at the RNA level and that a specific NPPA-AS isoform (NPPA-AS.1) can modulate the proportion of intron-retained NPPA.
###end p 36
###begin p 37
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 0 36 0 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>NPPA-AS </italic>forms RNA duplexes with <italic>NPPA</italic></bold>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 400 401 400 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 471 476 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 483 491 483 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
NPPA-AS forms RNA duplexes with NPPA. Reactions were performed with cloned intron-containing NPPA gene (pNPPA-mg2) and two antisense isoforms: pNPPA-AS-1 (A) and pNPPA-AS-3 (B). The agarose gels showing the results of PCR reactions using RNA samples treated (+) or non-treated (-) with RNase A. RT indicates reverse transcription reaction in the presence (+) or without (-) a reverse transcriptase. H2O, no template control; Ctrl, control reaction performed using cloned NPPA (A) or NPPA-AS (B) as a template.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 389 402 389 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA/NPPA-AS </italic>
The important regulatory role of endogenous noncoding RNAs, including antisense transcripts, has been proposed based on a number of large-scale transcription profiling studies. Because of the variety of functional mechanisms and lack of direct experimental support, the biological meaning of most of this noncoding transcription is still unclear. In the present study we have investigated NPPA/NPPA-AS sense-antisense transcript pair.
###end p 39
###begin p 40
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 355 363 355 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
Several studies have addressed the question whether some fraction of antisense transcripts may in fact be artifacts of reverse transcription reaction [28,29]. To exclude such artifacts from our study, we considered only NATs with two or more exons and consensus splice sequences. In addition, 3' RACE reactions further confirmed the strand-specificity of NPPA-AS by identification of two alternative polyadenylated 3' terminal exons (Figure 1C).
###end p 40
###begin p 41
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 531 536 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 679 684 679 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 770 772 770 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 840 845 840 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
NPPA is a functional candidate gene for elevated blood pressure, coding for an atrial natriuretic peptide (ANP), a member of a small family of endogenous peptide hormones. It is produced primarily by atrial cardiocytes in response to increasing cardiac wall tension. Association of specific NPPA variants with increased ANP levels as well as with lower blood pressure and reduced risk of hypertension [22] strongly support the central role of NPPA in the maintenance of blood pressure homeostasis. In addition, a region harbouring NPPA was among the eight loci identified in the meta-analysis of blood pressure genome-wide association studies [30]. Transcriptional regulation of NPPA and maturation of ANP have been studied quite extensively (for recent reviews see [31,32]) and our results add further evidence to the elaborate control of NPPA expression.
###end p 41
###begin p 42
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 322 333 322 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA+Intr1 </italic>
###xml 337 349 337 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA+Intr1+2</italic>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 599 610 599 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA+Intr1 </italic>
###xml 614 626 614 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA+Intr1+2</italic>
###xml 846 851 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 152 157 <span type="species:ncbi:9606">human</span>
During the expression analysis of NPPA mRNA we found the strongest expression of correctly spliced NPPA in heart and moderate expression in a number of human tissues, including prostate, pancreas and small intestine, for example (Figure 1B). In addition, we observed the expression of NPPA isoforms with retained introns (NPPA+Intr1 and NPPA+Intr1+2) in several tissues (Figure 1B). Normally, ANP is synthesized as a 153-amino acid preprohormone. Removal of the signal peptide creates a 126-amino acid prohormone that is further cleaved to form a mature C-terminal 27-amino acid ANP. In the case of NPPA+Intr1 and NPPA+Intr1+2, the ORF that starts with the first methionine (Met-1) of prepro-ANP encodes only for a signal peptide region and is terminated after the frameshift caused by the intron retention. An alternative ORF of intron-retained NPPA isoforms, starting with the methionine Met-51 includes the mature ANP sequence, but since the peptide encoded by this putative ORF does not contain a signal sequence, its proper processing and biological activity is doubtful.
###end p 42
###begin p 43
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 182 190 182 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 357 365 357 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 86 91 <span type="species:ncbi:9606">human</span>
The natural antisense transcript of NPPA, that we named NPPA-AS, is widely present in human tissues and displays a complex pattern of alternative splicing (Figure 1D). All different NPPA-AS splicing isoforms overlap with both exonic and intronic regions of NPPA, including intron-exon boundaries (Figure 1C). Such overlap pattern raised the hypothesis that NPPA-AS may be involved in the regulation of NPPA expression.
###end p 43
###begin p 44
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 317 325 317 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 413 418 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 513 518 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 697 702 697 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 706 713 706 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 732 737 732 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 91 96 <span type="species:ncbi:9606">human</span>
Overlapping antisense gene pairs are preferentially co-expressed or inversely expressed in human tissues [6,33,34], supporting a model of negative control by antisense RNA that proposes state of balance in case of co-expression or up- or downregulation in case of inverse expression. Interestingly, the expression of NPPA-AS was strongly correlated with the intron-retained, rather than correctly spliced form of NPPA (Figure 3), indicating that it may play a functional role in posttranscriptional regulation of NPPA expression. Such correlation, however, does not necessarily indicate causal relationship, because it can be affected by many factors including regulation of transcription of both NPPA and NPPA-AS, or modulation of NPPA splicing by other factors.
###end p 44
###begin p 45
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 608 613 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 617 625 617 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 633 634 633 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 647 652 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa </italic>
###xml 723 728 723 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 812 817 812 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa </italic>
###xml 844 851 844 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 1077 1079 1077 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1177 1182 1177 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 1190 1192 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 154 159 <span type="species:ncbi:9606">human</span>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
###xml 512 517 <span type="species:ncbi:10090">mouse</span>
###xml 522 527 <span type="species:ncbi:9606">human</span>
###xml 570 575 <span type="species:ncbi:10090">mouse</span>
###xml 580 585 <span type="species:ncbi:9606">human</span>
###xml 640 645 <span type="species:ncbi:10090">mouse</span>
###xml 717 722 <span type="species:ncbi:9606">human</span>
###xml 826 831 <span type="species:ncbi:10090">mouse</span>
###xml 945 950 <span type="species:ncbi:10090">mouse</span>
###xml 955 960 <span type="species:ncbi:9606">human</span>
###xml 965 970 <span type="species:ncbi:9606">human</span>
###xml 1021 1026 <span type="species:ncbi:10090">mouse</span>
###xml 1096 1101 <span type="species:ncbi:10090">mouse</span>
###xml 1106 1111 <span type="species:ncbi:9606">human</span>
Conservation often reflects functional significance of a nucleotide sequence. Among sense-antisense pairs, less than 7% are found to be conserved between human and mouse [35,36]. This may indicate that antisense transcripts are mostly species-specific, or alternatively, that the process of transcription, secondary structure or organization of the transcript rather than the primary sequence is functionally important. Among conserved sense-antisense pairs, about one third have identical expression pattern in mouse and human [37]. We found that expression profile in mouse and human is different for both NPPA and NPPA-AS (Figure 2). In mouse, Nppa is strongly expressed in some tissues (brain, lung, liver) where human NPPA is expressed weakly. We did not detect any alternatively spliced or intron-retained Nppa forms in mouse. In case of NPPA-AS, we found that neither the primary structure nor the expression pattern is conserved between mouse and human: in human it is expressed in all tissues examined, while in mouse the expression was observed only in brain (Figure 2A). However, both mouse and human antisense transcripts overlap with the exon-intron boundaries of NPPA (Figure 2B), implying that such genomic arrangement might be functionally significant.
###end p 45
###begin p 46
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 592 597 592 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 638 646 638 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 678 682 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 786 788 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 808 816 808 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 872 877 872 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 931 936 931 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 1118 1120 1118 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1195 1200 1195 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 1507 1509 1507 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1621 1626 1621 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1629 1631 1629 1631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 2006 2011 2006 2011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 2114 2119 2114 2119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 2176 2181 2176 2181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 389 397 <span type="species:ncbi:9606">patients</span>
###xml 1662 1667 <span type="species:ncbi:10090">mouse</span>
Although many antisense transcripts overlap with the intron-exon boundaries of the sense mRNA, the effect of endogenous antisense transcripts as splicing regulators is studied in detail only in a few cases [16,38]. Modulation of mRNA splicing by exogenous antisense oligonucleotides has gained more attention and its therapeutic potential has been established in clinical trials involving patients with Duchenne's muscular dystrophy [39]. Much less is known about the role of endogenous antisense RNAs in regulation of splicing or stability of different mRNA isoforms. The complementarity of NPPA and its antisense exons suggests that if NPPA-AS has a function in regulation of NPPA, it depends on the mechanisms that involve the interactions at the RNA level. Our results show (Figure 4B) that at least one NPPA-AS isoform can modulate the ratio of unspliced and spliced NPPA variants, by decreasing the levels of intron-retained NPPA form. Since we were using minigene expression system, we excluded the effects of such possible regulatory mechanisms like transcriptional interference and heterochromatin formation [17]. Currently we do not know what is the exact mechanism of intron-retained NPPA downregulation, but it is possible that the formation of the duplex RNA due to the complementary regions can lead to post-transcriptional regulation via different mechanisms like RNA masking (in which case the binding of factors required for splicing or export is blocked), RNA editing or RNA interference [14]. Although the role of RNA interference in NAT-mediated regulation in mammals has been controversial, Watanabe et al. [14] identified seventeen loci in mouse where siRNAs arose from interaction of sense-antisense transcripts of the same locus. Considering the large number of NATs in mammals, the real extent of siRNA biogenesis via endogenous sense-antisense RNA interaction in mammalian cells remains still unknown. It is also possible that since antisense transcription extends through entire NPPA locus and into the promoter region, the mechanisms like transcriptional interference and modulation of NPPA promoter elements can occur and affect the expression of NPPA independently.
###end p 46
###begin p 47
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 221 229 221 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
Although the biological role of NPPA antisense transcription needs further investigation, the regulatory role of NPPA in both adult cardiovascular system and in heart development during embryogenesis [23,24] suggest that NPPA-AS may be involved in fine-tuning of NPPA expression during embryonic development or in response to specific stimulus.
###end p 47
###begin title 48
Conclusion
###end title 48
###begin p 49
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 239 247 239 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 56 61 <span type="species:ncbi:9606">human</span>
We have identified the natural antisense transcripts of human blood pressure candidate genes and provide a detailed characterization of an antisense transcript associated with the NPPA gene. Our data support the biological significance of NPPA-AS by demonstrating that it (i) is widely expressed as a collection of canonically spliced isoforms, (ii) can directly interact with NPPA at the RNA level and (iii) is able to influence the levels of intron-retained NPPA variants.
###end p 49
###begin title 50
Methods
###end title 50
###begin title 51
###xml 19 29 19 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
Identification and in silico analysis of natural antisense transcripts
###end title 51
###begin p 52
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 882 883 882 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 463 468 <span type="species:ncbi:9606">human</span>
Candidate genes (n = 38) were selected according to the prior evidence of involvement in blood pressure regulation [see Additional file 1 - Table S1]. Most of the genes were selected based on the published data on the biology and genetics of blood pressure regulation. The selection included also genes responsible for the Mendelian forms of hypertension or hypotension, location near linkage peaks or quantitative trait loci (QTLs), reports on animal models and human association studies. Additional information was obtained from different resources (OMIM, ; NCBI GeneBank and NCBI Locuslink ; Ensembl ). Candidate gene list was also supplemented with loci involved in other cardiovascular diseases like myocardial infarction, coronary artery disease and stroke. The candidate genes were screened for antisense transcripts using recently published sense-antisense transcript data [8]. The structure and direction of the transcripts was verified using UCSC Genome Browser . To avoid random "transcriptional noise" and genomic DNA contamination, we considered only transcripts with at least two exons, canonical splice sites (GT/AG) and overlap with at least one exon of the sense gene. In addition, several transcripts had a polyadenylation signal and poly(A) tail, supporting together with canonical splice sites their strand-specificity.
###end p 52
###begin p 53
###xml 66 74 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
Multiple alignment of sequences corresponding to predicted ORF of NPPA-AS from different species was performed using ClustalW2 at . Sequence database searches were performed using BLAST programs at .
###end p 53
###begin title 54
PCR and sequencing
###end title 54
###begin p 55
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 216 222 216 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G3PDH </italic>
###xml 361 366 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa </italic>
###xml 393 400 393 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nppa-as</italic>
###xml 458 459 458 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 460 461 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 463 464 463 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 493 494 493 494 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 62 67 <span type="species:ncbi:9606">Human</span>
###xml 268 273 <span type="species:ncbi:10090">mouse</span>
###xml 355 360 <span type="species:ncbi:10090">mouse</span>
Expression analysis of NPPA and NPPA-AS was carried out using Human Multiple Tissue cDNA panels MTC I and II (BD Biosciences) and primers [see Additional file 1 - Table S2] that were designed using Primer3 program . G3PDH primers were included with MTC panels. PCR on mouse tissue-specific cDNAs was performed using oligonucleotides designed according to mouse Nppa gene and EST BQ771223 (for Nppa-as). PCR conditions were: 75 mM Tris-HCl (pH 8.8), 20 mM (NH4)2SO4, 0.01% Tween 20, 2.5 mM MgCl2, 250 muM dNTPs and 2.5 u per 100 mul Taq DNA Polymerase (Fermentas). Cycling conditions followed the touch-down procedure, namely initial denaturation at 94degreesC for 2 m, followed by 11 cycles at 94degreesC for 30 s, annealing for 30 s at temperatures decreasing from 62 to 57degreesC (with 0.5degreesC decremental in each cycle), 72degreesC for 60 s, and 30 cycles at 94degreesC for 30 s, 57degreesC for 30 s, 72degreesC for 60 s, and ending with an extension step at 72degreesC for 5 m.
###end p 55
###begin p 56
###xml 569 571 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
For sequencing, PCR products were extracted from agarose gel using NucleoSpin Extract II (Macherey-Nagel) and either cloned into the pTZ57R vector using InsT/Aclone Kit (Fermentas) or sequenced directly after ExoI/SAP (both Fermentas) treatment. Sequencing reactions were performed using BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) according to manufacturer's instructions and analyzed on ABI Prismtrade mark 3730xl DNA Analyzer. Sequencing results were manually analyzed using Bioedit software  and mapped to the genome using BLAT alignment tool [40] at the UCSC Genome Browser . Novel sequences obtained in this study have been submitted to GenBank database (-).
###end p 56
###begin title 57
3' RACE (rapid amplification of cDNA ends)
###end title 57
###begin p 58
The 3' RACE reactions were performed using GeneRacertrade mark Kit (Invitrogen) and 1 mug of total RNA isolated from semi-confluent HeLa cells grown in 5% CO2 at 37degreesC. Reverse transcription was performed using SuperScript III Reverse Transcriptase and GeneRacertrade mark Oligo dT Primer (both included in the kit). Amplification was carried out using GeneRacertrade mark or 3' primer and the following gene-specific primers: NPPA-AS-F1, -F2 or -F5. Nested PCR was performed using nested GeneRacertrade mark primer and suitable gene-specific primers.
###end p 58
###begin title 59
Construction of plasmids
###end title 59
###begin p 60
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 229 232 229 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 238 241 238 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 407 412 407 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 479 487 479 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 106 109 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 149 154 <span type="species:ncbi:9606">human</span>
###xml 343 348 <span type="species:ncbi:9606">human</span>
The vector pQM-Ntag/A (Quattromed, Estonia) was used to create expression constructs under the control of CMV promoter. NPPA gene was amplified from human genomic DNA using primers NPPA-GFXba and NPPA-GRBam and inserted into the XbaI and BamHI sites of pQM-Ntag/A. These primers amplify a 2069 bp fragment (chr1:11828358-11830426 according to human genome assembly hg18) of genomic DNA, including all three NPPA coding exons and both UTRs. Four constructs representing different NPPA-AS splicing isoforms were generated. pNPPA-AS-1 and -2 represent splicing isoforms NPPA-AS.1 and NPPA-AS.2 obtained with oligonucleotides NPPA-AS-F4 and NPPA-AS-R1. For generation of pNPPA-AS-3 and -4, 3' RACE products 3'RACE.1 and 3'RACE.2 were utilized. All constructs were sequenced using internal primers as well as universal primers flanking the insert cloning site.
###end p 60
###begin title 61
Transfection of expression constructs
###end title 61
###begin p 62
###xml 312 320 294 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
Cells were grown in 5% CO2 at 37degreesC and on the day before transfection were plated into 24-well plates using medium without antibiotics. Next day, cells were transfected using Lipofectaminetrade mark 2000 reagent (Invitrogen) and 1.0 mug of total plasmid DNA (0.2 mug of pNPPA-mg2 and 0.8 mug of any of the NPPA-AS constructs or empty vector). Cells were incubated at 37degreesC and RNA was isolated 24 hours later. For relative quantitation experiments, transfections were carried out in triplicate three times (total nine replicates).
###end p 62
###begin title 63
RNA isolation
###end title 63
###begin p 64
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Total RNA from cell lines and from mouse (male C57bl/6) tissues was isolated using TRIzol reagent (Invitrogen) and the quantity and quality of RNA was assessed using Nanodrop ND-1000 (Thermo Scientific). DNase treatment was performed using TURBO DNA-free Kittrade mark (Ambion) with 1 mug of RNA in a volume of 30 mul. cDNA was synthesized using 2 mug of total RNA and First Strand cDNA Synthesis Kit (Fermentas) according to manufacturer's instructions.
###end p 64
###begin title 65
Real-time quantitative PCR
###end title 65
###begin p 66
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS </italic>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA</italic>
###xml 366 373 366 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
###xml 424 430 424 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 786 791 786 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 862 867 862 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 966 972 966 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 1022 1028 1022 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HPRT1 </italic>
###xml 1151 1155 1151 1153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 1292 1296 1278 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 2335 2340 2291 2296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA </italic>
###xml 2376 2378 2332 2334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 2441 2447 2397 2403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 2451 2457 2407 2413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HPRT1 </italic>
###xml 62 67 <span type="species:ncbi:9606">human</span>
###xml 81 86 <span type="species:ncbi:9606">Human</span>
###xml 602 607 <span type="species:ncbi:10090">mouse</span>
###xml 714 719 <span type="species:ncbi:10090">mouse</span>
For investigation of expression levels of NPPA and NPPA-AS in human tissues, the Human Multiple Tissue cDNA panels MTC I and II (BD Biosciences) were used. Amplification was performed with the following primer pairs: NPPA-Ex1Ex2-F and NPPA-Ex2-R for quantification of spliced NPPA; NPPA-In1Ex2-F and NPPA-Ex2-R for detection of unspliced NPPA. For quantification of NPPA-AS, primers NPPA-ASRT-F4 and NPPA-ASRT-R4 were used. GAPDH was used as an endogenous control and amplified with primers GAPDH-S and GAPDH-AS. For quantification of spliced and unspliced NPPA from transfection experiments, RNA from mouse NIH3T3 cells was isolated and DNase-treated as described above. Primers were designed avoiding binding to mouse sequences to prevent nonspecific amplification. Correctly spliced NPPA mRNA was detected using primers NPPA-Ex1Ex2-F and NPPA-Ex2R, unspliced NPPA was detected using primers NPPA-In1Ex2-F and NPPA-Ex2-R. Two endogenous reference genes were used: GAPDH (amplified with primers GAPDH-S and GAPDH-AS) and HPRT1 (amplified with primers HPRT1-S and HPRT1-AS). The reactions were performed in the 96-well microtiter plate using ABI PRISM(R) 7900 Real-Time PCR cycler. The 25 mul reaction mixture consisted of 3 mul of 1:10 cDNA dilution, 12.5 mul of ABsolutetrade mark QPCR SYBR(R) Green ROX Mix (Thermo Scientific), 70 nM forward and reverse primer. The cycling parameters were: enzyme activation at 95degreesC for 15 m followed by 40 cycles 95degreesC for 15 s, 60degreesC for 30 s, 72degreesC for 30 s. Reactions were performed in triplicates for each biological replicate. As negative controls for DNA contamination, reactions without the reverse transcriptase were carried out. We performed control and optimization experiments for all primer pairs and selected for actual quantitation experiments primer pairs with amplification efficiency of 100 +/- 10%. During optimization, serial dilutions of template were used and the specificity of the PCR products was confirmed by the presence of a single peak during the dissociation curve analysis. Amplification efficiency of the reactions was 100 +/- 10% and intra- and inter-assay variation coefficients were below 3% and 8%, respectively. PCR efficiencies were calculated from ten-fold dilution series and relative expression of correctly spliced and intron-retained NPPA was calculated according to Pfaffl [41] by taking PCR efficiency into account. The geometric mean of GAPDH and HPRT1 was used as an endogenous control. Statistical significance of the results was analyzed using two-tailed Mann-Whitney test.
###end p 66
###begin title 67
Duplex detection
###end title 67
###begin p 68
###xml 797 802 781 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA:</italic>
###xml 803 813 787 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS-1 </italic>
###xml 870 875 854 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA:</italic>
###xml 876 886 860 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS-3 </italic>
RNA from NIH3T3 cells cotransfected with constructs pNPPAmg2 and pNPPA-AS-1 or pNPPA-AS-3 was isolated as described previously and treated with DNase (TURBO DNA-free Kittrade mark, Ambion) according to manufacturer's instructions and 0.5 mul of RNase A (10 mg/ml, Fermentas). RNase was inactivated with 0.5 mg/ml proteinase K treatment at the presence of 1% SDS for 30 min at 37degreesC. RNA was extracted with phenol/chloroform treatment and cDNA was synthesized using primers In1R (for NPPA-AS-1 duplex detection) or duplR (for NPPA-AS-3) and First Strand cDNA Synthesis Kit (Fermentas). In parallel, control experiments using RNAs not treated with RNase A and reverse transcriptions without reverse transcriptase were performed. PCR was performed with primers In1R and Ex1In1F for detection of NPPA::NPPA-AS-1 duplex and with primers duplF and duplR for detection of NPPA::NPPA-AS-3 duplex.
###end p 68
###begin title 69
Authors' contributions
###end title 69
###begin p 70
TA and ML designed the study, KK and ML selected and analysed the candidate genes, TA performed the experiments and carried out the analyses, TA and ML wrote the paper. All authors read and approved the final manuscript.
###end p 70
###begin title 71
Supplementary Material
###end title 71
###begin title 72
Additional file 1
###end title 72
###begin p 73
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Candidate genes for blood pressure regulation</bold>
Candidate genes for blood pressure regulation. The file contains the detailed list of blood pressure regulation candidate genes that were screened for the presence of natural antisense transcripts and oligonucleotide primer sequences used in this study.
###end p 73
###begin p 74
Click here for file
###end p 74
###begin title 75
Additional file 2
###end title 75
###begin p 76
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The genomic structure of natural antisense transcripts</bold>
###xml 205 212 205 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPPA-AS</italic>
The genomic structure of natural antisense transcripts. Additional information describing in detail the genomic structure of natural antisense transcripts and expression analysis and multiple alignment of NPPA-AS.
###end p 76
###begin p 77
Click here for file
###end p 77
###begin title 78
Acknowledgements
###end title 78
###begin p 79
###xml 209 214 <span type="species:ncbi:10090">mouse</span>
We thank Kristiina Rull for providing placental RNA, prof. Toivo Maimets for providing cell culture facilities, Urmo Vosa and Viljo Soo for technical assistance and Martti Laan, Kai Kisand and Sulev Kuuse for mouse tissue samples. We also thank Mart Speek for stimulating discussions and Jaana Mannik and Ana Rebane for critical review of the manuscript. This work was supported by Wellcome Trust grant no. 070191/z/03/z (to M.L.), Howard Hughes Medical Institute grant #55005617 (to M.L.), Estonian Ministry of Education and Science core grant no. 0182721s06 (to M.L.) and Estonian Science Foundation grant ETF6597 (to T.A.).
###end p 79
###begin article-title 80
###xml 64 69 <span type="species:ncbi:9606">human</span>
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project
###end article-title 80
###begin article-title 81
###xml 27 32 <span type="species:ncbi:9606">human</span>
Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution
###end article-title 81
###begin article-title 82
Genome-wide transcription and the implications for genomic organization
###end article-title 82
###begin article-title 83
The transcriptional landscape of the mammalian genome
###end article-title 83
###begin article-title 84
RNA regulation: a new genetics?
###end article-title 84
###begin article-title 85
Antisense transcription in the mammalian transcriptome
###end article-title 85
###begin article-title 86
###xml 82 102 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
Genome-wide prediction and identification of cis-natural antisense transcripts in Arabidopsis thaliana
###end article-title 86
###begin article-title 87
###xml 12 17 <span type="species:ncbi:9606">human</span>
Over 20% of human transcripts might form sense-antisense pairs
###end article-title 87
###begin article-title 88
Systematic identification of sense-antisense transcripts in mammalian cells
###end article-title 88
###begin article-title 89
###xml 56 61 <span type="species:ncbi:9606">human</span>
Widespread occurrence of antisense transcription in the human genome
###end article-title 89
###begin article-title 90
Antisense transcription: A critical look in both directions
###end article-title 90
###begin article-title 91
Genome-wide natural antisense transcription: coupling its regulation to its different regulatory mechanisms
###end article-title 91
###begin article-title 92
Multifaceted mammalian transcriptome
###end article-title 92
###begin article-title 93
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes
###end article-title 93
###begin article-title 94
###xml 46 70 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Antisense transcription controls cell fate in Saccharomyces cerevisiae
###end article-title 94
###begin article-title 95
A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition
###end article-title 95
###begin article-title 96
Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA
###end article-title 96
###begin article-title 97
###xml 93 98 <span type="species:ncbi:9606">human</span>
Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease
###end article-title 97
###begin article-title 98
###xml 24 29 <span type="species:ncbi:9606">human</span>
Molecular mechanisms of human hypertension
###end article-title 98
###begin article-title 99
How does salt retention raise blood pressure?
###end article-title 99
###begin article-title 100
###xml 12 17 <span type="species:ncbi:9606">human</span>
Genetics of human hypertension
###end article-title 100
###begin article-title 101
Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure
###end article-title 101
###begin article-title 102
Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease
###end article-title 102
###begin article-title 103
Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis
###end article-title 103
###begin article-title 104
###xml 97 101 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
###end article-title 104
###begin article-title 105
###xml 52 57 <span type="species:ncbi:9606">human</span>
Patterns of variant polyadenylation signal usage in human genes
###end article-title 105
###begin article-title 106
Analysis of a noncanonical poly(A) site reveals a tripartite mechanism for vertebrate poly(A) site recognition
###end article-title 106
###begin article-title 107
###xml 119 124 <span type="species:ncbi:9606">human</span>
Systematic analysis of transcribed loci in ENCODE regions using RACE sequencing reveals extensive transcription in the human genome
###end article-title 107
###begin article-title 108
Antisense artifacts in transcriptome microarray experiments are resolved by actinomycin D
###end article-title 108
###begin article-title 109
Genome-wide association study identifies eight loci associated with blood pressure
###end article-title 109
###begin article-title 110
Molecular biology of the natriuretic peptide system: implications for physiology and hypertension
###end article-title 110
###begin article-title 111
Natriuretic peptides: update on Peptide release, bioactivity, and clinical use
###end article-title 111
###begin article-title 112
###xml 63 68 <span type="species:ncbi:9606">human</span>
Genome-wide analysis of coordinate expression and evolution of human cis-encoded sense-antisense transcripts
###end article-title 112
###begin article-title 113
Expression profiling of antisense transcripts on DNA arrays
###end article-title 113
###begin article-title 114
Comparative analysis of cis-encoded antisense RNAs in eukaryotes
###end article-title 114
###begin article-title 115
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Complex Loci in human and mouse genomes
###end article-title 115
###begin article-title 116
Comparative expression analysis uncovers novel features of endogenous antisense transcription
###end article-title 116
###begin article-title 117
Post-transcriptional regulation of thyroid hormone receptor expression by cis-acting sequences and a naturally occurring antisense RNA
###end article-title 117
###begin article-title 118
Local dystrophin restoration with antisense oligonucleotide PRO051
###end article-title 118
###begin article-title 119
BLAT - the BLAST-like alignment tool
###end article-title 119
###begin article-title 120
A new mathematical model for relative quantification in real-time RT-PCR
###end article-title 120

